NeuroMetrix Announces $7.0 Million Private Placement Of Preferred Stock Post author:Sam Post published:July 10, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Patient Dies in Cellectis' Groundbreaking CAR-T Trial, Forcing a Halt to Trials September 4, 2017 Alnylam Stock Catapults as Genetic Disease Drug Meets All Phase III Goals September 19, 2017 Alder CEO Is Stepping Down March 20, 2018